Open original FDA record ↗Recall record
- FDA identifier
- Z-0137-2022
- Company in FDA record
- GE Healthcare, LLC
- FDA classification date
- Oct 16, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Under certain conditions, some slices may be missing which can lead to a gap of anatomy in the 3D Volume images.
Source facts
- Action
- GE issued an Urgent Medical Device Correction letter to customers with affected devices. This letter informs the customer of the issue and provides safety instructions for the continued use of the device. GE Healthcare will correct all affected devices at no cost to the customer. In the U.S., this letter will be sent by a traceable means. This letter will be sent to the following titles within the affected accounts: Director of Clinical/Radiology, Risk Manager/Hospital Administrator.
- Initiated
- 2021-08-26
- Root cause
- Software design
- Terminated
- 2026-05-04
- Distribution
- Distribution in United States to AZ, CA, FL, GA, IL, LA, MA, MD, MN, NC, NH, NJ, NY, OH, OK, TX, VA, WA, and Puerto Rico OUS distribution to: Australia, Belgium, Canada, Chile, Colombia, France, Germany, Italy, Japan, Korea, Poland, Saudi Arabia, Spain, Sweden, Turkey, UAE, and UK
- Recall number
- Z-0137-2022
- Recall status
- Terminated
- CDRH record ID
- 189210
- FDA classified
- 2021-10-16
- Recall event number
- 88665